Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07215325 · ClinicalTrials.gov registry record · Phase 4
Got Doxy- 'Flipping the Script' on STI PEP
A Phase 4 study of Sexually Transmitted Infections (STI), sponsored by Emory University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 200
- Enrollment target
- 2
- Study locations
NCT07215325 is a Phase 4 study of Sexually Transmitted Infections (STI) that is actively recruiting participants, run by Emory University. The registered enrollment target is 200 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT07215325, a Phase 4 study of Sexually Transmitted Infections (STI), is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 200 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is being done to test the effects of doxycycline on inflammation and the bacteria in the body in people with HIV and in people on HIV pre-exposure prophylaxis. This drug is approved by the Food and Drug Administration (FDA) for the treatment of bacterial infections. The study team will investigate whether the drug has additional effects on inflammation or on the bacteria that live in the body.
Conditions Studied
Interventions
- OTHER Observation
- DRUG Doxycycline monohydrate 200 mg
Study Locations (2)
Georgia
- Grady Health System (non-CRN) - Atlanta
- Hope Clinic - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-10-22 |
| Est. Completion | 2028-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07215325
The ClinicalTrials.gov registry entry for NCT07215325 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sexually Transmitted Infections (STI) appearing as the primary indexed condition, and to 2 interventions - of which Observation is the first listed.
NCT07215325 reports 2 study locations spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT07215325 about?
NCT07215325 is a clinical study titled "Got Doxy- 'Flipping the Script' on STI PEP". This study is being done to test the effects of doxycycline on inflammation and the bacteria in the body in people with HIV and in people on HIV pre-exposure prophylaxis. This drug is approved by the Food and Drug Administration (FDA) for the treatment of bacterial infections. The study team will i...
What is the current status of trial NCT07215325?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 200 participants. The study started on 2025-10-22. Estimated completion is 2028-09.
What conditions does trial NCT07215325 study?
This clinical trial studies the following conditions: Sexually Transmitted Infections (STI).
What interventions are being tested in trial NCT07215325?
The interventions under investigation include: Observation (OTHER), Doxycycline monohydrate 200 mg (DRUG).
Who is sponsoring clinical trial NCT07215325?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07215325 being conducted?
This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sexually Transmitted Infections (STI)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.